Optimized Biventricular Pacing Allograft Recipients

Stopped early · Phase 1/Phase 2

Conditions studied: Dilated Cardiomyopathy, Ischemic Cardiomyopathy

In brief

This study tests optimization of biventricular pacing (BiVP) in patients with dilated cardiomyopathy (DCM) or ischemic cardiomyopathy (ICM) during cardiac transplantation in patients with advanced cardiac failure. It examines the effects of atrioventricular delay (AVD), interventricular delay (VVD or RLD), and left ventricular pacing site (LVPS) on cardiac output (CO). BiVP results are compared to traditional atrial (AAI) pacing at an identical heart rate.

Key facts

Study ID

NCT01290822

Run by

Henry M. Spotnitz

People needed

12

Starts

2007-01-01

Expected to finish

2011-03-01

Last updated by the study team

2016-10-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• New York Heart Association (NYHA) heart failure class III/IV
• Left Ventricular Ejection Fraction (LVEF) <36%
• QRS >120 msec

You may not qualify if…

• Intracardiac shunts
• Sinus tachycardia >120 bpm
• Second or third degree heart block
• Previous cardiac surgery
• Mechanical circulatory assistance
• Atrial fibrillation

Where it is running

• Columbia University Medial Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.